Texas on Thursday became the latest state to take insulin manufacturers and the top entities managing prescription drug benefits to court over allegations that the companies have conspired to artificially raise the price of diabetes medications.
The lawsuit from Texas Attorney General Ken Paxton (R) filed in Texas District Court, Travis County, includes allegations that insulin manufacturers 
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.


